1.Department of Colorectal and Laparoscopic Surgery,Chase Farm Hospital,Enfield,USA;2.Department of Laparoscopic Surgery,Chase Farm Hospital,Enfield,USA;3.Department of Nuclear Medicine,University College Hospital London,London,UK
Abstract:
Background
18Fluoro-2-Deoxy Glucose (18 FDG) positron emission tomography (PET) impacts upon the management of recurrent colorectal cancer (CRC) but is limited by anatomical localisation. The development of integrated positron emission and computerised tomography (PET/CT) yields high anatomical resolution combined with the PET data. We evaluate the added value of PET/CT over PET alone.